| Dr Eoin Gorman, DPM | |
|
2061 Cheyenne Ct, Grafton, WI 53024-9368 | |
| (262) 376-1934 | |
| (262) 375-2076 |
| Full Name | Dr Eoin Gorman |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 12 Years |
| Location | 2061 Cheyenne Ct, Grafton, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881949907 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1050 (Wisconsin) | Primary |
| 213E00000X | Podiatrist | 1050 (Wisconsin) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia St Marys Hospital Milwaukee Inc | 5890604722 | 279 |
News Archive
Dental and heart experts are set to publish joint recommendations for medical and oral health professionals and patients.
Despite a critical shortage of primary care in the United States less than 25 percent of newly minted doctors go into this field and only a tiny fraction, 4.8 percent, set up shop in rural areas, according to a study by researchers at the George Washington University School of Public Health and Health Services.
The diabetes medication metformin hydrochloride was associated with decreased weight gain in a small clinical trial of children and adolescents with autism spectrum disorder who were taking atypical antipsychotics to treat symptoms of irritability and agitation, according to an article published online by JAMA Psychiatry.
Depomed, Inc. today reported financial results for the first quarter ended March 31, 2010.
Inspire Pharmaceuticals, Inc. announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.
› Verified 1 days ago
| Provider Name | Columbia St Marys Hospital Milwaukee Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023064482 PECOS PAC ID: 5890604722 Enrollment ID: O20031105000057 |
News Archive
Dental and heart experts are set to publish joint recommendations for medical and oral health professionals and patients.
Despite a critical shortage of primary care in the United States less than 25 percent of newly minted doctors go into this field and only a tiny fraction, 4.8 percent, set up shop in rural areas, according to a study by researchers at the George Washington University School of Public Health and Health Services.
The diabetes medication metformin hydrochloride was associated with decreased weight gain in a small clinical trial of children and adolescents with autism spectrum disorder who were taking atypical antipsychotics to treat symptoms of irritability and agitation, according to an article published online by JAMA Psychiatry.
Depomed, Inc. today reported financial results for the first quarter ended March 31, 2010.
Inspire Pharmaceuticals, Inc. announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eoin Gorman, DPM 4425 N Port Washington Rd, Glendale, WI 53212-1082 Ph: (414) 326-2218 | Dr Eoin Gorman, DPM 2061 Cheyenne Ct, Grafton, WI 53024-9368 Ph: (262) 376-1934 |
News Archive
Dental and heart experts are set to publish joint recommendations for medical and oral health professionals and patients.
Despite a critical shortage of primary care in the United States less than 25 percent of newly minted doctors go into this field and only a tiny fraction, 4.8 percent, set up shop in rural areas, according to a study by researchers at the George Washington University School of Public Health and Health Services.
The diabetes medication metformin hydrochloride was associated with decreased weight gain in a small clinical trial of children and adolescents with autism spectrum disorder who were taking atypical antipsychotics to treat symptoms of irritability and agitation, according to an article published online by JAMA Psychiatry.
Depomed, Inc. today reported financial results for the first quarter ended March 31, 2010.
Inspire Pharmaceuticals, Inc. announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.
› Verified 1 days ago